MLPR As A Diagnostic Marker For Acute Pulmonary Embolism (NCT07023705) | Clinical Trial Compass
CompletedNot Applicable
MLPR As A Diagnostic Marker For Acute Pulmonary Embolism
Egypt53 participantsStarted 2024-01-01
Plain-language summary
A retrospective study to assess the utility of hematological marker (monocyte to large platelet ratio) to diagnose patients with pulmonary embolism
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Only patients with the results of full blood count and white blood cell differentiation, measured before the treatment of suspected PE.
* Patients underwent CT pulmonary angiography to confirm or exclude pulmonary embolism diagnosis.
Exclusion Criteria:
* Patient with history of any myeloproliferative disorder, myelofibrosis, Glanzmann thrombasthenia, May-Hegglin anomaly, Bernard-Soulier syndrome, suspicion of disseminated intravascular coagulation.
* Patient receiving any anticoagulant drug at a therapeutic dose.
* Patient with blood transfusion in the last 2 months.
* Patients with acute coronary syndrome, pulmonary edema.
* Patient on immunosuppressive drugs , Oral contraceptive pills .
* Patients with severe renal or hepatic disease.
* Patients with Stroke.
* Patients with malignancy.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Monocyte-to-Large Platelet Ratio (MLPR)
Timeframe: At emergency department admission (baseline lab measurement) before any treatment.